These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

993 related items for PubMed ID: 26791235

  • 1. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H, Jiang X, Wang J, Li Y, Song CX, Chen P, Li S, Gurbuxani S, Arnovitz S, Wang Y, Weng H, Neilly MB, He C, Li Z, Chen J.
    Cancer Lett; 2016 Mar 28; 372(2):157-65. PubMed ID: 26791235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TET1 plays an essential oncogenic role in MLL-rearranged leukemia.
    Huang H, Jiang X, Li Z, Li Y, Song CX, He C, Sun M, Chen P, Gurbuxani S, Wang J, Hong GM, Elkahloun AG, Arnovitz S, Wang J, Szulwach K, Lin L, Street C, Wunderlich M, Dawlaty M, Neilly MB, Jaenisch R, Yang FC, Mulloy JC, Jin P, Liu PP, Rowley JD, Xu M, He C, Chen J.
    Proc Natl Acad Sci U S A; 2013 Jul 16; 110(29):11994-9. PubMed ID: 23818607
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L, Sun Y, Wang J, Jiang H, Muntean AG.
    Oncotarget; 2016 May 03; 7(18):25208-23. PubMed ID: 27007052
    [Abstract] [Full Text] [Related]

  • 5. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G, Morello G, Aveic S, Pinazza M, Minuzzo S, Frasson C, Persano L, Bonvini P, Viola G, Bresolin S, Tregnago C, Paganin M, Pigazzi M, Indraccolo S, Basso G.
    Oncotarget; 2017 Apr 18; 8(16):26129-26141. PubMed ID: 28412727
    [Abstract] [Full Text] [Related]

  • 6. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, Wang Y, Li S, Huang H, Neilly MB, Wang GG, Jiang X, Liu PP, Jin J, Chen J.
    Cancer Res; 2016 Feb 01; 76(3):619-29. PubMed ID: 26747896
    [Abstract] [Full Text] [Related]

  • 7. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
    Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H, Jiang X, Arnovitz S, Xu M, Hong GM, Elkahloun AG, Neilly MB, Wunderlich M, Larson RA, Le Beau MM, Mulloy JC, Liu PP, Rowley JD, Chen J.
    Proc Natl Acad Sci U S A; 2013 Jul 09; 110(28):11511-6. PubMed ID: 23798388
    [Abstract] [Full Text] [Related]

  • 8. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    Ono R, Masuya M, Inoue N, Shinmei M, Ishii S, Maegawa Y, Maharjan BD, Katayama N, Nosaka T.
    PLoS One; 2021 Jul 09; 16(3):e0248425. PubMed ID: 33705482
    [Abstract] [Full Text] [Related]

  • 9. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.
    Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, Chen P, He C, You D, Zhang S, Wang J, Arnovitz S, Elkahloun A, Price C, Hong GM, Ren H, Kunjamma RB, Neilly MB, Matthews JM, Xu M, Larson RA, Le Beau MM, Slany RK, Liu PP, Lu J, Zhang J, He C, Chen J.
    Cancer Cell; 2012 Oct 16; 22(4):524-35. PubMed ID: 23079661
    [Abstract] [Full Text] [Related]

  • 10. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.
    Kim HS, Oh SH, Kim JH, Kim JY, Kim DH, Lee SJ, Choi SU, Park KM, Ryoo ZY, Park TS, Lee S.
    Haematologica; 2017 Nov 16; 102(11):e434-e437. PubMed ID: 28798069
    [No Abstract] [Full Text] [Related]

  • 11. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
    Su R, Gong JN, Chen MT, Song L, Shen C, Zhang XH, Yin XL, Ning HM, Liu B, Wang F, Ma YN, Zhao HL, Yu J, Zhang JW.
    Oncotarget; 2016 Nov 22; 7(47):77430-77443. PubMed ID: 27764807
    [Abstract] [Full Text] [Related]

  • 12. Aberrant TRPM4 expression in MLL-rearranged acute myeloid leukemia and its blockade induces cell cycle arrest via AKT/GLI1/Cyclin D1 pathway.
    Wang F, Wu P, Gong S, Chen Y, Gao J, Wang S, Shen Q, Tao H, Hua F, Zhou Z, Zou Z, Ma T, Jia Y.
    Cell Signal; 2020 Aug 22; 72():109643. PubMed ID: 32320859
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J, Zha J, Shi Y, Li Y, Yuan D, Chen Q, Lin F, Fang Z, Yu Y, Dai Y, Xu B.
    Clin Epigenetics; 2019 Oct 07; 11(1):137. PubMed ID: 31590682
    [Abstract] [Full Text] [Related]

  • 15. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
    Chen Y, Jones KL, Anastassiadis K, Kranz A, Stewart AF, Grembecka J, Meyerson M, Ernst P.
    Exp Hematol; 2019 Jan 07; 69():37-42. PubMed ID: 30315824
    [Abstract] [Full Text] [Related]

  • 16. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
    Willer A, Jakobsen JS, Ohlsson E, Rapin N, Waage J, Billing M, Bullinger L, Karlsson S, Porse BT.
    Leukemia; 2015 May 07; 29(5):1018-31. PubMed ID: 25349154
    [Abstract] [Full Text] [Related]

  • 17. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
    Bindels EM, Havermans M, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, Rombouts E, Armstrong SA, Taskesen E, Haanstra JR, Beverloo HB, Döhner H, Hudson WA, Kersey JH, Delwel R, Kumar AR.
    Blood; 2012 Jun 14; 119(24):5838-49. PubMed ID: 22553314
    [Abstract] [Full Text] [Related]

  • 18. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H, Chu Y, Wang L, Chen X, Chen Y, Cheng H, Zhang L, Zhou Y, Yang FC, Cheng T, Xu M, Zhang X, Zhou J, Yuan W.
    Int J Cancer; 2017 Jul 15; 141(2):324-335. PubMed ID: 28411381
    [Abstract] [Full Text] [Related]

  • 19. Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia.
    Brzezinka K, Nevedomskaya E, Lesche R, Steckel M, Eheim AL, Haegebarth A, Stresemann C.
    J Hematol Oncol; 2019 Jun 28; 12(1):66. PubMed ID: 31253180
    [Abstract] [Full Text] [Related]

  • 20. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
    Fu JF, Yen TH, Huang YJ, Shih LY.
    Neoplasia; 2019 May 28; 21(5):469-481. PubMed ID: 30974389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.